Back to top
more

Cabot (CBT)

(Delayed Data from NYSE)

$73.71 USD

73.71
582,782

+1.71 (2.38%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $76.65 +2.94 (3.99%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cabot (CBT) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Cabot (CBT) delivered earnings and revenue surprises of 20.71% and 18.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Avient (AVNT) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Avient (AVNT) delivered earnings and revenue surprises of 4.21% and 2.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cabot (CBT) Shares Up 25% in 6 Months: What's Driving It?

by Zacks Equity Research

Cabot (CBT) gains on a recovery in demand from the pandemic-led slowdown, its disciplined execution of operations and targeted growth initiatives.

Zacks Equity Research

Best Income Stocks to Buy for March 30th

by Zacks Equity Research

VINP, EPR, and CBT made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 30, 2022.

Zacks Equity Research

This is Why Cabot (CBT) is a Great Dividend Stock

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.

Zacks Equity Research

Here's What Makes Cabot (CBT) Stock a Solid Choice Right Now

by Zacks Equity Research

Cabot (CBT) gains on a recovery in demand, its disciplined execution of operations and targeted growth initiatives.

Zacks Equity Research

International Paper (IP) Aims to Sell its Stake in Russian Ilim JV

by Zacks Equity Research

International Paper (IP) considers the sale of its 50% stake in Ilim JV in Russia over the Ukraine invasion.

Rimmi Singhi headshot

Here's Why You Should Own These 4 High Earnings Yield Stocks

by Rimmi Singhi

In situations of extreme volatility, value investing could be one of the most effective investment approaches. MRO, NTR, PPC and CBT are some value stocks that boast high earnings yield.

Zacks Equity Research

Wheaton (WPM) Q4 Earnings & Sales Miss Estimates, Down Y/Y

by Zacks Equity Research

Wheaton's (WPM) top line declines due to a reduction in average realized gold equivalent price, partly offset by an increase in the number of Gold Equivalent Ounces sold.

Zacks Equity Research

Linde (LIN) Gains as CEO Purchases 3,750 Ordinary Shares

by Zacks Equity Research

Late last month, Linde (LIN) pleased its shareholders with an announcement of a dividend hike and a new share buyback program.

Zacks Equity Research

Franco-Nevada (FNV) Q4 Earnings Meet, Revenues Top Estimates

by Zacks Equity Research

Franco-Nevada's (FNV) Q4 top-line results reflect benefits of higher realized oil and gas prices and contribution from the Vale Royalty acquisition.

Zacks Equity Research

Why Cabot (CBT) is a Great Dividend Stock Right Now

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.

Zacks Equity Research

Is Cabot (CBT) Stock Outpacing Its Basic Materials Peers This Year?

by Zacks Equity Research

Here is how Cabot (CBT) and Gold Fields (GFI) have performed compared to their sector so far this year.

Nalak Das headshot

5 High-Yielding Mid Cap Stocks to Buy Amid Global Uncertainty

by Nalak Das

We have narrowed our search to five mid-cap stocks with strong growth potential for 2022. These are: CBT, HII, HP, DTM and NJR.

Zacks Equity Research

Cabot (CBT) Up 22% in 3 Months: What's Driving the Stock?

by Zacks Equity Research

Strong earnings performance in the fiscal first quarter and upbeat outlook have contributed to the rally in Cabot's (CBT) shares.

Zacks Equity Research

Great Panther (GPL) Q4 Earnings Miss, Sales Beat Estimates

by Zacks Equity Research

Great Panther (GPL) reports a loss in the fourth quarter of 2021. The company expects gold equivalent production between 100,000 ounces and 119,000 ounces in 2022.

Zacks Equity Research

Sociedad Quimica (SQM) Q4 Earnings and Sales Top Estimates

by Zacks Equity Research

Sociedad Quimica (SQM) benefits from a significant rise in global potassium prices driven by the shortage of potash and potassium-based fertilizers in Q4.

Zacks Equity Research

Carpenter Technology's (CRS) 4500-Ton Press Resumes Operation

by Zacks Equity Research

Carpenter Technology's (CRS) 4500-ton press at its Reading, PA facility is now back in service, which will help in meeting customer demand in the Aerospace supply chain.

Zacks Equity Research

Cabot (CBT) Wraps Up Sale of Purification Solutions Business

by Zacks Equity Research

Cabot's (CBT) sale of Purification Solutions business reflects that the company is undertaking action to focus its portfolio so that it can invest resources to strengthen the core business segments.

Zacks Equity Research

Amyris (AMRS) Q4 Earnings Lag Estimates, Sales Fall Y/Y

by Zacks Equity Research

Amyris (AMRS) sees strong revenues in its consumer segment in Q4 driven by the accelerated growth of its consumer brands.

Zacks Equity Research

Daqo New Energy (DQ) Q4 Earnings and Sales Lag Estimates

by Zacks Equity Research

Daqo New Energy (DQ) benefits from higher selling prices in Q4 amid headwinds from a spike in raw material costs.

Zacks Equity Research

Cabot (CBT) Wraps Up Acquisition of Tokai Carbon Black Plant

by Zacks Equity Research

Cabot's (CBT) buyout of Tokai Carbon Black Plant boosts its manufacturing capacity to support growth of its Battery Materials product line.

Zacks Equity Research

GrowGeneration (GRWG) Q4 Earnings Beat, Revenues Improve Y/Y

by Zacks Equity Research

GrowGeneration (GRWG) reports year-over-year improvement in Q4 revenues despite the ongoing weakness in the cannabis industry. It expects revenues between $415 million and $445 million in 2022.

Zacks Equity Research

Veritiv (VRTV) Q4 Earnings Surpass Estimates, Improve Y/Y

by Zacks Equity Research

Veritiv's (VRTV) Q4 results gain from strong packaging sales growth and operational improvements.

Zacks Equity Research

Why Is Cabot (CBT) Up 15.8% Since Last Earnings Report?

by Zacks Equity Research

Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.